Title:
ANTI-TUMOR AGENT COMBINED WITH KINASE INHIBITOR
Document Type and Number:
Japanese Patent JP2013166702
Kind Code:
A
Abstract:
To provide a new combination therapy agent showing a significant anti-tumor effect.
An anti-tumor agent comprises a combination of a mixed agent comprising tegafur, gimeracil and oteracil potassium, cisplatin, and TSU-68 or a salt thereof.
Inventors:
NAKADATE YUSUKE
Application Number:
JP2010128607A
Publication Date:
August 29, 2013
Filing Date:
June 04, 2010
Export Citation:
Assignee:
TAIHO PHARMACEUTICAL CO LTD
International Classes:
A61K31/404; A61K31/4412; A61K31/513; A61K31/53; A61K33/243; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Alga Patent Office, a patent business corporation
Miyuki Ariga
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Miyuki Ariga
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Previous Patent: PRODUCTION METHOD OF LONG-CHAIN SATURATED ALIPHATIC PRIMARY ALCOHOL
Next Patent: ANTITUMOR AGENT CONTAINING INDOLE COMPOUND
Next Patent: ANTITUMOR AGENT CONTAINING INDOLE COMPOUND